Sjogren's syndrome in mice carrying the lpr(cg) gene and the therapeutic efficacy of an immunosuppressive agent FK506

Pathology International

Volumn 49, Issue 2, 1999, Pages 133-140

  Yang, Jihong ^a   Shikata, Nobuaki ^a   Yasuda, Takuwa ^b   Matsuzawa, Akio ^b   Tsubura, Airo ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Autoimmunity; Immunotherapy; Ipr(cg) gene; Sjogren's syndrome; Superantigen

Indexed keywords

TACROLIMUS; ANTINUCLEAR ANTIBODY; DNA; FAS ANTIGEN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; GENE THERAPY; GENETIC COMPLEMENTATION; HETEROZYGOTE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; MOUSE; MYOEPITHELIUM; NONHUMAN; PRIORITY JOURNAL; SJOEGREN SYNDROME; ANIMAL; C3H MOUSE; CBA MOUSE; COMPARATIVE STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; LACRIMAL APPARATUS; MALE; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; PATHOLOGY; PROTEINURIA; SUBMANDIBULAR GLAND;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIGENS, CD95; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; LACRIMAL APPARATUS; MALE; MICE; MICE, INBRED C3H; MICE, INBRED CBA; MICE, INBRED MRL LPR; PROTEINURIA; SJOGREN'S SYNDROME; SUBMANDIBULAR GLAND; TACROLIMUS;

EID: 0032587294     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.1999.00834.x     Document Type: Article

References (32)

1. 1 Mountz JD, Gause WC, Jonsson R. Murine models for systemic lupus erythematosus and Sjögren's syndrome. Curr. Opin. Rheumatol. 1991; 3: 738-756.
2. 2 Jabs DA, Prendergast RA. Murine models of Sjögren's syndrome. Adv. Exp. Med. Biol. 1994; 350: 623-630.
3. cg, that complements the gld gene in induction of lymphadenopathy in the mouse. J. Exp. Med. 1990; 171: 519-531.
4. 4 Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314-317.
5. cg gene on the MRL background. Immunology 1992; 76: 498-504.
6. cg: A novel mutant gene. Int. Rev. Immunol. 1994; 11: 193-210.
7. cg. Clin. Exp. Immunol. 1990; 79: 123-129.
8. 8 Thomson AW, Starzl TE. FK506 and autoimmune disease: Perspective and prospects. Autoimmunity 1992; 12: 303-313.
9. 9 Yoshimoto T, Nagase H, Nakano H, Matsuzawa A, Nariuchi HA. Vβ8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice. Eur. J. Immunol. 1994; 24: 1612-1619.
10. 10 Matsuzawa A, Nakano H, Yoshimoto T, Sayama K. Biology of mouse mammary tumor virus (MMTV). Cancer Lett. 1995; 90: 3-11.
11. + T cells by murine mammary tumor virus (FM) superantigen with broad specificity of T cells receptor β-chain variable region. Virology 1996; 223: 387-391.
12. 12 Tanaka S, Matsuzawa A, Kalo H, Ezaki K, Sudo K, Yamanouchi K. Inbred strains of mice maintained at the Institute of Medical Science, University of Tokyo. Jpn. J. Exp. Med. 1987; 57: 241-245.
13. 13 Chisholm DM, Mason DK. Labial salivary gland biopsy in Sjögren's disease. J. Clin. Pathol. 1968; 21: 656-660.
14. 14 Tsubura A, Morii S. Mouse mammary tumor virus (MMTV) particles in extraorbital lacrimal and urethral glands of endogenous MMTV-carrying mice. Jpn. J. Exp. Med. 1987; 57: 255-260.
15. 15 Kino T, Hatanaka H, Hashimoto M et al. FK506, a novel immunosuppressant isolated from a streptomyces. I: Fermentation, isolation, and physico-chemical and biological characteristics. J. Antibiot.(Tokyo) 1987; 40: 1249-1255.
16. + cells by Mtv-2 in the DDD mouse. Eur. J. Immunol. 1993; 23: 2434-2439.
17. 17 Jonsson R, Takowski A, Bäckman K, Holmdahl R, Klareskog L. Sialadenitis in the MRL-1 mouse: Morphological and immunohistochemical characterization of resident and infiltrating cells. Immunology 1987; 60: 611-616.
18. 18 Huffman RW, Alspaugh MA, Waggie KS, Durham JB, Walker SE. Sjögren's syndrome in MRL/1 and MRL/n mice. Arthritis Rheum. 1984; 27: 157-165.
19. 19 Jabs DA, Alexander EL, Green WR. Ocular inflammation in autoimmune MRL/Mp mice. Invest. Ophthalmol. Vis. Sci. 1985; 26: 1223-1229.
20. 20 Scott J, Wolff A, Fox PC. Histologic assessment of the submandibular glands in autoimmune disease-prone mice. J. Oral Pathol. Med. 1990; 19: 131-135.
21. 21 Ono M, Rocha FJ, Sullivan DA. Immunocytochemical location and hormonal control of androgen receptors in lacrimal tissues of the female MRL/Mp-Ipr/Ipr mouse model of Sjögren's syndrome. Exp. Eye Res. 1995; 61: 659-666.
22. 22 Yamano S, Renard JN, Mizuno F et al. Retrovirus in salivary glands from patients with Sjögren's syndrome. J. Clin. Pathol. 1997; 50: 223-230.
23. 23 Watson ME, Rao JK, Gilkson GS et al. Genetic analysis of MRL-Ipr mice: Relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J. Exp. Med. 1992; 176: 1645-1656.
24. 24 Izui S, Kelley VE, Masuda K, Yoshida H, Roths JB, Murphy ED. Induction of various autoantibodies by mutant gene Ipr in several strains of mice. J. Immunol. 1984; 133: 227-233.
25. 25 Takabayashi K, Koike T, Kurasawa K et al. Effect of FK-506, a novel immunosuppressive drug on murine systemic lupus erythematosus. Clin. Immunol. Immunopathol. 1989; 51: 110-117.
26. 26 Yamamoto K, Mori A, Nakahama T, Ito M, Okudaira H, MiyamotoT. Experimental treatment of autoimmune MRL-Ipr/Ipr mice with immunosuppressive compound FK506. Immunology 1990; 69: 222-227.
27. 27 Furukawa F, Imamura S, Takigawa M. FK506: Therapeutic effects on lupus dermatoses in autoimmune-prone MRL/Mp-Ipr/Iprmice. Arch. Dermatol. Res. 1995; 287: 558-563.
28. 28 Takahashi S, Itoh J, Nose M, Ono M, Yamamoto T, Kyogoku M. Cloning and cDNA sequence analysis of nephritogenic monoclonal antibodies derived from an MRL/Ipr mouse. Mol. Immunol. 1993; 30: 177-182.
29. 29 Takahashi S, Fossati L, Iwamoto M et al. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J. Clin. Invest. 1996; 94: 1597-1604.
30. 30 Hayashi Y, Hamano H, Haneji N, Ishimaru N, Yanagi K. Biased T cell receptor Vβ gene usage during specific stages of the development of autoimmune sialadenitis in the MRU/Ipr mouse model of Sjögren's syndrome. Arthritis Rheum. 1995; 38: 1077-1084.
31. 31 Skarstein K, Holmdahl R, Johannessen AC, Goldschmidt T, Jonsson R. Short-term administration of selected anti-T-cell receptor Vβ chain specific MoAb reduces sialadenitis in MRL/ Iprmice. Scand. J. Immunol. 1995; 42: 529-534.
32. 32 Hayashi Y, Haneji N, Hamano H, Yanagi K. Transfer of Sjögren's syndrome-like autoimmune lesions into SCID mice and prevention of lesions by anti-CD4 and anti-T cell receptor antibody treatment. Eur. J. Immunol. 1994; 24: 2826-2831.